SCS is a potent and selective partial inhibitor of β1-containing GABAA receptors (IC50 values are 4.5, 5.3 and 7.9 nM at α2β1γ1θ, α2β1γ1 and α2β1γ2s GABAA receptors respectively). SCS may bind allosterically to a novel site on GABAA receptor.
Thompson et al (2004) Salicylidene salicylhydrazide, a selective inhibitor of b1-containing GABAA receptors. Br.J.Pharmacol. 142 97.